Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESTRO 2022 | Recent advances in radiotherapy for oligometastatic disease

Joachim Widder, MD, PhD, Medical University of Vienna & Vienna General Hospital, Vienna, Austria, talks on the recent advances in radiotherapy that have made it possible for patients with oligometastatic disease to undergo their full radiotherapy treatment in a single session. This is made possible in part due to the low toxicity of the treatment, as well as the development of very high precision treatment using planning scans. This interview took place at the European Society for Radiotherapy and Oncology (ESTRO) 2022 annual congress in Copenhagen, Denmark, and online.